HomeCompareOTMO vs MRK

OTMO vs MRK: Dividend Comparison 2026

OTMO yields 37.74% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 OTMO wins by $147.1K in total portfolio value
10 years
OTMO
OTMO
● Live price
37.74%
Share price
$5.30
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$204.8K
Annual income
$32,963.30
Full OTMO calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — OTMO vs MRK

📍 OTMO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOTMOMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OTMO + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OTMO pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OTMO
Annual income on $10K today (after 15% tax)
$3,207.55/yr
After 10yr DRIP, annual income (after tax)
$28,018.81/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, OTMO beats the other by $19,422.09/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OTMO + MRK for your $10,000?

OTMO: 50%MRK: 50%
100% MRK50/50100% OTMO
Portfolio after 10yr
$131.3K
Annual income
$21,538.54/yr
Blended yield
16.41%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

OTMO
Analyst Ratings
2
Buy
Consensus: Buy
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OTMO buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOTMOMRK
Forward yield37.74%2.81%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$204.8K$57.7K
Annual income after 10y$32,963.30$10,113.78
Total dividends collected$151.4K$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: OTMO vs MRK ($10,000, DRIP)

YearOTMO PortfolioOTMO Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$14,474$3,773.58$11,213$373.04+$3.3KOTMO
2$20,591$5,104.42$12,667$512.06+$7.9KOTMO
3$28,819$6,786.84$14,439$708.14+$14.4KOTMO
4$39,714$8,877.43$16,640$988.16+$23.1KOTMO
5$53,927$11,433.11$19,432$1,394.07+$34.5KOTMO
6$72,211$14,509.20$23,057$1,992.90+$49.2KOTMO
7$95,424$18,157.54$27,889$2,894.79+$67.5KOTMO
8$124,528$22,424.56$34,518$4,286.29+$90.0KOTMO
9$160,594$27,349.58$43,912$6,494.35+$116.7KOTMO
10$204,799$32,963.30$57,714$10,113.78+$147.1KOTMO

OTMO vs MRK: Complete Analysis 2026

OTMOStock

Otonomo Technologies Ltd. provides an automotive data service platform and marketplace that enables car manufacturers, drivers, and service providers to be part of a connected ecosystem. The company offers cabin data, including the state of doors and windows, ADAS, and infotainment data; engine-related information, such as fuel, oil, error codes or battery voltage, and state of charge; maintenance data comprising time or distance traveled and diagnostic trouble codes; data related to the specific vehicles, which include making, model, year, and fuel type; driving data consisting of location, distance travelled, odometer, and heading and speed; and environmental data that include external weather and temperature, and road hazards and road signs. Its data is used for various services, such as preventative maintenance, EV management, emergency services, on-demand fueling, insurance, and smart cities. The company collects vehicle-specific and aggregated data from vehicle data providers, such as vehicle manufacturers, vehicle fleet operators, and telematics service providers, as well as licenses software. It serves in North America, the Asia Pacific, Europe, the Middle East, and Africa. Otonomo Technologies Ltd. was founded in 2015 and is headquartered in Herzliya, Israel.

Full OTMO Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this OTMO vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OTMO vs SCHDOTMO vs JEPIOTMO vs OOTMO vs KOOTMO vs MAINOTMO vs JNJOTMO vs ABBVOTMO vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.